These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9433365)

  • 21. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis.
    Wilson AM; Sims EJ; Orr LC; Coutie WJ; White PS; Gardiner Q; Lipworth BJ
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):344-9. PubMed ID: 11686428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system.
    Day JH; Briscoe M; Rafeiro E; Chapman D; Kramer B
    Ann Allergy Asthma Immunol; 2001 Dec; 87(6):474-81. PubMed ID: 11770694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis.
    Murris-Espin M; Melac M; Charpentier JC; Didier A
    Ann Allergy Asthma Immunol; 1998 May; 80(5):399-403. PubMed ID: 9609610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of efficacy, safety, and skin test inhibition of cetirizine and astemizole.
    Berkowitz RB; Dockhorn R; Lockey R; Findlay S; Howland WC; Mitchell DQ; Woehler T
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):363-8. PubMed ID: 8612120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study between 10 and 20 mg of cetirizine in the symptomatic treatment of seasonal allergic rhinoconjunctivitis].
    Hernández J; Negro JM; Pascual A; Sola J; Miralles JC; Mora A; Pagán JA; García FJ; López JD; Sarrió F
    Allergol Immunopathol (Madr); 1993; 21(5):179-84. PubMed ID: 8160562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
    Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis.
    Bachert C; Bousquet J; Canonica GW; Durham SR; Klimek L; Mullol J; Van Cauwenberge PB; Van Hammée G;
    J Allergy Clin Immunol; 2004 Oct; 114(4):838-44. PubMed ID: 15480324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
    Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G
    Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitis.
    Sastre J; Mullol J; Valero A; Valiente R;
    Curr Med Res Opin; 2012 Jan; 28(1):121-30. PubMed ID: 22077106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid symptom relief in rhinitis.
    Bousquet J
    Clin Exp Allergy; 1999 Mar; 29 Suppl 1():25-9. PubMed ID: 10209702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults.
    Gehanno P; Bremard-Oury C; Zeisser P
    Ann Allergy Asthma Immunol; 1996 Jun; 76(6):507-12. PubMed ID: 8673684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cetirizine and pseudoephedrine retard, given alone or in combination, in patients with seasonal allergic rhinitis.
    Grosclaude M; Mees K; Pinelli ME; Lucas M; Van de Venne H
    Rhinology; 1997 Jun; 35(2):67-73. PubMed ID: 9299654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-ranging comparative evaluation of cetirizine in patients with seasonal allergic rhinitis.
    DuBuske L
    Ann Allergy Asthma Immunol; 1995 Apr; 74(4):345-54. PubMed ID: 7719897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid anti-inflammatory action of azelastine eyedrops for ongoing allergic reactions.
    Ciprandi G; Cosentino C; Milanese M; Tosca MA
    Ann Allergy Asthma Immunol; 2003 Apr; 90(4):434-8. PubMed ID: 12722967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined mediator blockade or topical steroid for treating the unified allergic airway.
    Barnes ML; Menzies D; Fardon TC; Burns P; Wilson AM; Lipworth BJ
    Allergy; 2007 Jan; 62(1):73-80. PubMed ID: 17156345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis.
    Philip G; van Adelsberg J; Loeys T; Liu N; Wong P; Lai E; Dass SB; Reiss TF
    J Allergy Clin Immunol; 2009 Nov; 124(5):942-8.e1-9. PubMed ID: 19748656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr.
    Chen ST; Lu KH; Sun HL; Chang WT; Lue KH; Chou MC
    Pediatr Allergy Immunol; 2006 Feb; 17(1):49-54. PubMed ID: 16426255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study.
    Martínez-Cócera C; De Molina M; Martí-Guadaño E; Pola J; Conde J; Borja J; Pérez I; Arnaiz E; Izquierdo I;
    J Investig Allergol Clin Immunol; 2005; 15(1):22-9. PubMed ID: 15864879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity.
    Ciprandi G; Buscaglia S; Catrullo A; Pesce G; Fiorino N; Montagna P; Bagnasco M; Canonica GW
    Clin Exp Allergy; 1997 Feb; 27(2):182-91. PubMed ID: 9061218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.